[Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer].

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Actas Urológicas Españolas

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12918151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection.

  2001cited by this paper
• [PSA:alpha 1-antichymotrypsin ratio/total PSA in the diagnosis of prostatic cancer in the range of total PSA from 4 to 10 ng/ml].

  2001cited by this paper
• Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

  2000cited by this paper
• The influence of prostate volume on the prostate‐specific antigen (PSA) level adjusted for the transition zone volume and free‐to‐total PSA ratio: a prospective study

  2000cited by this paper
• Prostate specific antigen adjusted for transition zone volume

  2000cited by this paper
• Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study.

  1998cited by this paper
• Transition zone prostate specific antigen density: lack of use in prediction of prostatic carcinoma.

  1998cited by this paper
• Prostate specific antigen density of the transition zone for early detection of prostate cancer.

  1998cited by this paper
• Prostate-specific antigen density.

  1997cited by this paper
• Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction.

  1997cited by this paper
• Prostate specific antigen adjusted for the transition zone volume as an indicator of prostate cancer.

  1997cited by this paper
• Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations

  1997cited by this paper
• The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/ml.

  1996cited by this paper
• Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.

  1995cited by this paper
• Evaluation of patients with diseases of the prostate using prostate-specific antigen density.

  1995cited by this paper
• Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate.

  1995cited by this paper
• The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels.

  1995cited by this paper
• Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels.

  1995cited by this paper
• Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma.

  1994cited by this paper
• Prostate specific antigen density in patients with histologically proven prostate carcinoma

  1994cited by this paper
• Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate.

  1994cited by this paper
• Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection.

  1994cited by this paper
• Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

  1994cited by this paper
• The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice.

  1994cited by this paper
• The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma.

  1993cited by this paper
• PSA density (PSAD). Role in patient evaluation and management.

  1993cited by this paper
• The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen.

  1992cited by this paper
• Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

  1991cited by this paper
• Correlation between prostate-specific antigen and prostate volume, evaluated by transrectal ultrasonography: usefulness in diagnosis of prostate cancer.

  1990cited by this paper
• Prostate‐specific antigen and prostate gland volume: Correlation and clinical application

  1990cited by this paper

• The role of targeted biopsy methods in the prostate cancer diagnosis

  2021cites this paper
• Value of prostate-specific antigen density in negative or equivocal lesions on multiparametric magnetic resonance imaging.

  2020cites this paper
• The roles of prostate‐specific antigen (PSA) density, prostate volume, and their zone‐adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng/mL

  2017cites this paper
• Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer

  2014cites this paper
• [Evaluation of prostate specific antigen (PSA) adjusted to transition zone in prostatic cancer detection].

  2005cites this paper